European Commission seeks biopharma feedback on Novo-Catalent deal — reportnews2024-11-14T17:55:02+00:00November 14th, 2024|Endpoints News|
Lonza expands bioconjugates factory; WuXi Bio adds capacity in Germany news2024-11-14T16:23:41+00:00November 14th, 2024|Endpoints News|
Novo Nordisk to phase out its production of human insulin pens globallynews2024-11-14T16:09:23+00:00November 14th, 2024|Endpoints News|
Merck KGaA’s life science unit is still feeling the Covid demand declinenews2024-11-14T14:29:08+00:00November 14th, 2024|Endpoints News|
FDA drug inspections have fallen from 2016 peak, GAO saysnews2024-11-13T18:19:08+00:00November 13th, 2024|Endpoints News|
Otsuka and ICU Medical forge IV manufacturing network to supply the USnews2024-11-13T14:15:19+00:00November 13th, 2024|Endpoints News|
AstraZeneca budgets another $2B to boost manufacturing and R&D in USnews2024-11-12T12:08:44+00:00November 12th, 2024|Endpoints News|
Thermo Fisher consolidates viral vector work in Massachusetts, cuts 160 workers news2024-11-11T18:10:32+00:00November 11th, 2024|Endpoints News|
FDA action puts Chinese API manufacturer on import block listnews2024-11-08T20:09:48+00:00November 8th, 2024|Endpoints News|
Coherus restarts biosimilar supply after delays; Novavax ends Covid vaccine deal with UKnews2024-11-07T16:45:15+00:00November 7th, 2024|Endpoints News|
